Category: Anticancer Drugs

Bortezomib, sold under the brand name Velcade among others, is a medication used to treat multiple myeloma and mantle cell lymphoma. It is a proteasome inhibitor, which means it blocks the activity of a protein called the proteasome. The proteasome is responsible for breaking down proteins in cells, including cancer cells.    Bortezomib is a […]

Vinorelbine is a chemotherapy medication that is sometimes used to treat non-small cell lung cancer (NSCLC). It is often used in combination with other chemotherapy drugs, such as cisplatin or pemetrexed. Vinorelbine works by interfering with the growth and division of cancer cells. When used to treat NSCLC, vinorelbine can help to shrink tumors and […]

Vemurafenib treats a specific type of melanoma, the most serious form of skin cancer, as a targeted therapy medication. It works by targeting a mutated gene called B R A F, which is found in many melanoma cells. How Vemurafenib Works: B R A F Mutation: In certain types of melanomas, the B R A […]

Pralsetinib in Geriatric Patients: A Brief Overview Pralsetinib is a targeted cancer medication used to treat certain types of non-small cell lung cancer (NSCLC). While specific data on the use of pralsetinib in geriatric patients may be limited, here’s a general overview of factors to consider: Factors to Consider for Geriatric Use Age-Related Physiological Changes: […]

Pralsetinib for Pediatric Use: A Complex Landscape Pralsetinib is a targeted cancer medication designed to inhibit the activity of RET proto-oncogene receptor tyrosine kinase. While primarily developed for adult patients, its potential use in pediatric populations with RET-driven tumors is being explored. Pediatric Considerations and Challenges: Limited Clinical Data: The majority of clinical trials evaluating […]

Pralsetinib: A Targeted Therapy for RET-Driven Cancers Pralsetinib is a targeted therapy medication used to treat certain types of cancer driven by the RET gene. It works by blocking the activity of the RET protein, which is involved in the growth and survival of cancer cells. Approved Uses: Non-small cell lung cancer: Pralsetinib is approved […]